With Eli Lilly's cut in insulin prices, a race to the bottom begins
Drug pricing experts predict the move will help other initiatives to bring lower-cost insulin to market and maintain pressure on Eli Lilly to keep its prices down.
Stay updated with breaking news from Michael Sinha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug pricing experts predict the move will help other initiatives to bring lower-cost insulin to market and maintain pressure on Eli Lilly to keep its prices down.
When drugmaker Eli Lilly announced Wednesday it will slash the list price for some of its insulin products following years of criticism from lawmakers and activists that the price of the lifesaving hormone had become unaffordable, the news raised questions about what will happen to other efforts to provide low-cost insulin.
Massachusetts halted sales of all vape products. That drove consumers to the illicit market, where toxic vitamin E oil circulated.